Sodium ferric gluconate complex
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||2089.309 g·mol−1|
|3D model (JSmol)|
Sodium ferric gluconate complex, sold under the brand name Ferrlecit, is an intravenously administered iron medication for the treatment of iron deficiency anemia in adults and in children aged six years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. The macromolecule has an apparent molecular weight of 289,000 – 440,000 Dalton.
The most common side effects in adults are nausea, vomiting and/or diarrhea, injection site reaction, hypotension, cramps, hypertension, dizziness, dyspnea, chest pain, leg cramps, and pain. In children the most common side effects are hypotension, headache, hypertension, tachycardia and vomiting.
- "Sodium ferric gluconate complex Use During Pregnancy". Drugs.com. 16 December 2019. Retrieved 2 April 2020.
- "Ferrlecit- sodium ferric gluconate complex injection". DailyMed. 25 September 2019. Retrieved 2 April 2020.
- http://www.drugbank.ca/drugs/DB09517, retrieved 2020-Jun-21
- "Sodium ferric gluconate complex". Drug Information Portal. U.S. National Library of Medicine.
|This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.|